Condition

Viral Infections clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Viral Infections clinical trials that are recruiting, at sites in 4 countries (most in France (1), China (1), Colombia (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Viral Infections clinical trials

StudyPhaseWhereStatusRegistered
Respiratory infections in newborns and children up to five years — Cali, Valle del Cauca Department and 1 other locations Recruiting Nov 25, 2025
Stopping antibiotics early in older adults hospitalized with a viral lung infection — Amiens Recruiting Jun 22, 2025
Emergency PanorOmics Wide Association for Respiratory Infections — Hong Kong Recruiting Apr 20, 2022

All recruiting trials (3)

Related topics

Bacterial InfectionsCohort StudyLower Respiratory Tract Infection (LRTI)PneumoniaRespiratory Tract Infections (RTI)Sepsis

Quick answers

How many Viral Infections clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (1 trial), China (1 trial), Colombia (1 trial), Panama (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.